Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Exact Sciences Corp EXAS

Healthcare Biotechnology
Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test... see more

Recent & Breaking News (NDAQ:EXAS)

Exact Sciences to host second-quarter 2014 results, annual meeting webcasts and calls

Business Wire July 16, 2014

Exact Sciences President, CEO and Chairman Kevin T. Conroy Named EY Entrepreneur Of The Year(TM) 2014 Award winner for the Midwest

Business Wire June 20, 2014

Exact Sciences to Participate in Goldman Sachs Global Healthcare Conference

Business Wire June 5, 2014

Exact Sciences to Participate in June Investor Conferences

Business Wire May 28, 2014

Exact Sciences to Participate in May Investor Conferences

Business Wire May 5, 2014

Exact Sciences Reports First-Quarter 2014 Financial Results

Business Wire May 1, 2014

Exact Sciences to Host First-Quarter 2014 Results Webcast and Call

Business Wire April 25, 2014

Exact Sciences Announces Successful Completion of Public Offering of Common Stock

Business Wire April 9, 2014

Exact Sciences Prices Public Offering of Common Stock

Business Wire April 4, 2014

Exact Sciences Announces Proposed Public Offering of Common Stock

Business Wire April 2, 2014

Exact Sciences Announces FDA Advisory Committee Unanimously Recommends Approval of Cologuard

Business Wire March 27, 2014

Exact Sciences' Stock Trading Halted Today; FDA Advisory Committee Meeting to Review Premarket Approval Application

Business Wire March 27, 2014

Exact Sciences Announces Appointment of Kevin Conroy as Chairman of the Board; David Thompson to Serve as Lead Independent Director

Business Wire March 21, 2014

Exact Sciences' DeeP-C Study Results Published in New England Journal of Medicine

Business Wire March 19, 2014

Exact Sciences Corporation [EXAS] to Ring The NASDAQ Stock Market Opening Bell

GlobeNewswire March 17, 2014

Exact Sciences to Participate in ROTH Conference

Business Wire March 3, 2014

Exact Sciences Reports Fourth-Quarter and Full-Year 2013 Financial Results

Business Wire February 20, 2014

Exact Sciences to Host Fourth-Quarter 2013 Results Webcast and Call

Business Wire February 10, 2014

U.S. Food and Drug Administration confirms date for Exact Sciences' advisory committee

Business Wire February 5, 2014

Exact Sciences to participate in Leerink Swann Global Healthcare Conference

Business Wire February 4, 2014